NASDAQ Biotechnology Index (NBI) Market Capitalization
Explore all companies in the NASDAQ Biotechnology Index ranked by market capitalization
Total Market Cap: $1.54 Trillion Constituents: 263 Country: USA
Total Market Cap (USD)
$1.54 Trillion
Constituent Companies
263
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 51 |
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE |
% | $3.68 Billion | Healthcare | Biotechnology | $71.09 | -1.13% |
| 52 |
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND |
% | $3.62 Billion | Healthcare | Biotechnology | $202.91 | -4.05% |
| 53 |
ADMA Biologics Inc
NASDAQ:ADMA |
% | $3.61 Billion | Healthcare | Biotechnology | $15.84 | +4.55% |
| 54 |
SpringWorks Therapeutics Inc
NASDAQ:SWTX |
% | $3.48 Billion | Healthcare | Biotechnology | $46.99 | +0.02% |
| 55 |
Scholar Rock Holding Corp
NASDAQ:SRRK |
% | $3.35 Billion | Healthcare | Biotechnology | $40.26 | +0.62% |
| 56 |
Legend Biotech Corp
NASDAQ:LEGN |
% | $3.25 Billion | Healthcare | Biotechnology | $19.10 | +1.87% |
| 57 |
Xenon Pharmaceuticals Inc
NASDAQ:XENE |
% | $3.24 Billion | Healthcare | Biotechnology | $54.66 | -1.03% |
| 58 |
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX |
% | $3.21 Billion | Healthcare | Biotechnology | $37.28 | -0.56% |
| 59 |
Terns Pharmaceuticals Inc
NASDAQ:TERN |
% | $3.06 Billion | Healthcare | Biotechnology | $46.07 | -0.97% |
| 60 |
Indivior PLC Ordinary Shares
NASDAQ:INDV |
% | $2.86 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $30.97 | -0.45% |
| 61 |
Spyre Therapeutics Inc.
NASDAQ:SYRE |
% | $2.84 Billion | Healthcare | Biotechnology | $44.07 | +10.48% |
| 62 |
Dyne Therapeutics Inc
NASDAQ:DYN |
% | $2.81 Billion | Healthcare | Biotechnology | $18.13 | +1.17% |
| 63 |
Immunitybio Inc
NASDAQ:IBRX |
% | $2.76 Billion | Healthcare | Biotechnology | $8.21 | -2.15% |
| 64 |
Erasca Inc
NASDAQ:ERAS |
% | $2.76 Billion | Healthcare | Biotechnology | $13.51 | -0.81% |
| 65 |
Denali Therapeutics Inc
NASDAQ:DNLI |
% | $2.74 Billion | Healthcare | Biotechnology | $20.57 | +0.00% |
| 66 |
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD |
% | $2.71 Billion | Healthcare | Biotechnology | $21.39 | +3.78% |
| 67 |
Ideaya Biosciences Inc
NASDAQ:IDYA |
% | $2.65 Billion | Healthcare | Biotechnology | $34.79 | +5.14% |
| 68 |
Supernus Pharmaceuticals Inc
NASDAQ:SUPN |
% | $2.60 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $50.21 | +0.60% |
| 69 |
Veracyte Inc
NASDAQ:VCYT |
% | $2.59 Billion | Healthcare | Diagnostics & Research | $32.92 | +2.46% |
| 70 |
Travere Therapeutics Inc
NASDAQ:TVTX |
% | $2.56 Billion | Healthcare | Biotechnology | $28.03 | +0.83% |
| 71 |
Twist Bioscience Corp
NASDAQ:TWST |
% | $2.51 Billion | Healthcare | Diagnostics & Research | $45.01 | +4.00% |
| 72 |
Amneal Pharmaceuticals, Inc. Class A Common Stock
NYSE:AMRX |
% | $2.33 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $12.18 | +2.01% |
| 73 |
Zai Lab Ltd
NASDAQ:ZLAB |
% | $2.24 Billion | Healthcare | Biotechnology | $19.06 | +3.76% |
| 74 |
Beam Therapeutics Inc
NASDAQ:BEAM |
% | $2.24 Billion | Healthcare | Biotechnology | $25.49 | +1.31% |
| 75 |
Immunovant Inc
NASDAQ:IMVT |
% | $2.23 Billion | Healthcare | Biotechnology | $25.00 | +2.42% |
| 76 |
Tarsus Pharmaceuticals Inc
NASDAQ:TARS |
% | $2.22 Billion | Healthcare | Biotechnology | $68.90 | +1.38% |
| 77 |
Arcutis Biotherapeutics Inc
NASDAQ:ARQT |
% | $2.09 Billion | Healthcare | Biotechnology | $22.76 | +0.04% |
| 78 |
Summit Therapeutics PLC
NASDAQ:SMMT |
% | $2.02 Billion | Healthcare | Biotechnology | $16.18 | +0.34% |
| 79 |
Avadel Pharmaceuticals PLC
NASDAQ:AVDL |
% | $1.98 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $21.64 | +0.05% |
| 80 |
Ultragenyx
NASDAQ:RARE |
% | $1.98 Billion | Healthcare | Biotechnology | $21.82 | +2.25% |
| 81 |
Disc Medicine Inc.
NASDAQ:IRON |
% | $1.96 Billion | Healthcare | Biotechnology | $60.89 | +1.42% |
| 82 |
Mesoblast Ltd
NASDAQ:MESO |
% | $1.94 Billion | Healthcare | Biotechnology | $14.63 | +0.55% |
| 83 |
10X Genomics Inc
NASDAQ:TXG |
% | $1.91 Billion | Healthcare | Health Information Services | $16.69 | -11.18% |
| 84 |
NewAmsterdam Pharma Company N.V. Ordinary Shares
NASDAQ:NAMS |
% | $1.86 Billion | Healthcare | Biotechnology | $29.79 | +4.09% |
| 85 |
Ocular Therapeutix Inc
NASDAQ:OCUL |
% | $1.86 Billion | Healthcare | Biotechnology | $8.63 | -1.48% |
| 86 |
Vera Therapeutics Inc
NASDAQ:VERA |
% | $1.84 Billion | Healthcare | Biotechnology | $40.05 | +0.23% |
| 87 |
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH |
% | $1.84 Billion | Healthcare | Biotechnology | $14.31 | +2.58% |
| 88 |
Edgewise Therapeutics Inc
NASDAQ:EWTX |
% | $1.80 Billion | Healthcare | Biotechnology | $29.78 | +0.64% |
| 89 |
Syndax Pharmaceuticals Inc
NASDAQ:SNDX |
% | $1.76 Billion | Healthcare | Biotechnology | $24.04 | +2.30% |
| 90 |
Zymeworks Inc. Common Stock
NASDAQ:ZYME |
% | $1.75 Billion | Healthcare | Biotechnology | $23.62 | +3.23% |
| 91 |
Alumis Inc
NASDAQ:ALMS |
% | $1.74 Billion | Healthcare | Biotechnology | $26.20 | +5.60% |
| 92 |
Recursion Pharmaceuticals Inc
NASDAQ:RXRX |
% | $1.71 Billion | Healthcare | Biotechnology | $3.39 | -0.88% |
| 93 |
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX |
% | $1.70 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $9.30 | +13.14% |
| 94 |
Sarepta Therapeutics Inc
NASDAQ:SRPT |
% | $1.65 Billion | Healthcare | Biotechnology | $16.66 | +1.59% |
| 95 |
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA |
% | $1.64 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $46.50 | +1.57% |
| 96 |
Vericel Corp Ord
NASDAQ:VCEL |
% | $1.62 Billion | Healthcare | Biotechnology | $32.29 | -0.75% |
| 97 |
Genmab AS
NASDAQ:GMAB |
% | $1.62 Billion | Healthcare | Biotechnology | $26.56 | +1.61% |
| 98 |
Adaptive Biotechnologies Corp
NASDAQ:ADPT |
% | $1.59 Billion | Healthcare | Biotechnology | $13.32 | +1.14% |
| 99 |
Apellis Pharmaceuticals Inc
NASDAQ:APLS |
% | $1.57 Billion | Healthcare | Biotechnology | $18.87 | -0.37% |
| 100 |
Dynavax Technologies Corporation
NASDAQ:DVAX |
% | $1.56 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $15.50 | +0.00% |
Complete list of all companies in the NBI index ranked by market capitalization. Track index constituent performance and market values. View all indices